Janey Youngblom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Janey Youngblom has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jon Weil
Independent Scholar California US
2 shared publications - Andria G. Besser
International Registry of Mosaic Embryo Transfers (IRMET), New York, New York, USA
1 shared publication Christina Ren
California State University, Stanislaus, Turlock, CA
1 shared publication- David E. Sandberg
Susan B. Meister Child Health and Evaluation Research Center, Department of Pediatrics, University of Michigan, Ann Arbor, USA
1 shared publication - Erica M. Weidler
University of Arizona College of Medicine – Phoenix
1 shared publication - Grace Kavanaugh
Institute of Cancer Research, London, UK
1 shared publication
Latest Publications
- 4 December 2024
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (3)
Experiences of individuals receiving “Not Parent Expected” results through direct‐to‐consumer genetic testing
As direct‐to‐consumer genetic testing (DTC‐GT) grows in popularity, the unanticipated “Not Parent Expected” (NPE) result has become more prevalent. An NPE result is the discovery that one parent, often the father, is not a biological parent. This study explores the impact of making an NPE discovery through DTC‐GT. Twenty‐five participants were interviewed and transcripts were analyzed using thematic analysis. NPE discovery had an impact on participants' personal identity. They frequently reported having experienced grief and loss among other emotions whether the discovery confirmed a participant's prior suspicions or was unexpected. Strained parent/child relationships prior to the NPE discovery and further negative impact on the relationship after DTC‐GC were common themes. Connection to newly identified biological parents and family was a common goal reported by many participants, with mixed outcomes of such connections. Further research will assist in deepening our understanding and confirming the findings of this study.
- 4 December 2024
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (3)
Experiences of individuals receiving “Not Parent Expected” results through direct‐to‐consumer genetic testing
As direct‐to‐consumer genetic testing (DTC‐GT) grows in popularity, the unanticipated “Not Parent Expected” (NPE) result has become more prevalent. An NPE result is the discovery that one parent, often the father, is not a biological parent. This study explores the impact of making an NPE discovery through DTC‐GT. Twenty‐five participants were interviewed and transcripts were analyzed using thematic analysis. NPE discovery had an impact on participants' personal identity. They frequently reported having experienced grief and loss among other emotions whether the discovery confirmed a participant's prior suspicions or was unexpected. Strained parent/child relationships prior to the NPE discovery and further negative impact on the relationship after DTC‐GC were common themes. Connection to newly identified biological parents and family was a common goal reported by many participants, with mixed outcomes of such connections. Further research will assist in deepening our understanding and confirming the findings of this study.
- 21 May 2021
- Published by Springer Nature in Endocrine
- Vol. 73 (3) , 723-733
“Good practices” in pediatric clinical care for disorders/differences of sex development
Purpose To define, benchmark, and publicize elements of quality care (i.e., “good practices”) for pediatric patients with disorders/differences of sex development (DSD). Methods Principles of quality care were identified by literature review; consensus exists for 11 good practices and adherence was evaluated through online survey of 21 North American clinical sites. Results Strong uptake was observed for many practices, particularly specialty participation (n ≥ 17 of 21 sites for most core specialties); point of contact (n = 18); expertise in gender dysphoria/dissatisfaction (n = 20); and DSD-specific continuing medical education (n = 18). Greater variability was apparent for frequency of peer support referrals (n = 12 universally practiced); standardized questionnaires for routine assessment of psychosocial adaptation (n = 13) and gender development (n = 10); consistently clarifying patient/family values in decision-making (n = 15); genital exam protocols that exclude trainee education as primary reason (n = 15); and internal patient-tracking efforts (n = 5–10 of 20 sites). Conclusion This study employed a novel approach to designate DSD good practices and identified areas of consistency and variation in these DSD clinical practices. Good practice benchmarking facilitates quality assessment within and across sites, promotes continuous improvement, and empowers stakeholders in locating and delivering high quality care.
- 21 May 2021
- Published by Springer Nature in Endocrine
- Vol. 73 (3) , 723-733
“Good practices” in pediatric clinical care for disorders/differences of sex development
Purpose To define, benchmark, and publicize elements of quality care (i.e., “good practices”) for pediatric patients with disorders/differences of sex development (DSD). Methods Principles of quality care were identified by literature review; consensus exists for 11 good practices and adherence was evaluated through online survey of 21 North American clinical sites. Results Strong uptake was observed for many practices, particularly specialty participation (n ≥ 17 of 21 sites for most core specialties); point of contact (n = 18); expertise in gender dysphoria/dissatisfaction (n = 20); and DSD-specific continuing medical education (n = 18). Greater variability was apparent for frequency of peer support referrals (n = 12 universally practiced); standardized questionnaires for routine assessment of psychosocial adaptation (n = 13) and gender development (n = 10); consistently clarifying patient/family values in decision-making (n = 15); genital exam protocols that exclude trainee education as primary reason (n = 15); and internal patient-tracking efforts (n = 5–10 of 20 sites). Conclusion This study employed a novel approach to designate DSD good practices and identified areas of consistency and variation in these DSD clinical practices. Good practice benchmarking facilitates quality assessment within and across sites, promotes continuous improvement, and empowers stakeholders in locating and delivering high quality care.
- 1 September 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 114 (3) , e19
EMBRYO TRANSFER BASED ON PREIMPLANTATION GENETIC TESTING: A CRITICAL ASSESSMENT OF CURRENT PRACTICE AND POLICY GUIDELINES
- 1 September 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 114 (3) , e19
EMBRYO TRANSFER BASED ON PREIMPLANTATION GENETIC TESTING: A CRITICAL ASSESSMENT OF CURRENT PRACTICE AND POLICY GUIDELINES